Cargando…

Can B- cell based immunotherapy be our new perspective to exit cancer?

Detalles Bibliográficos
Autores principales:	Thomas, Anela, Smitha, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Cancer Neoterics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269306/ https://www.ncbi.nlm.nih.gov/pubmed/32508441 http://dx.doi.org/10.4103/jomfp.JOMFP_121_20

Ejemplares similares

The dendritic cell tool for oral cancer treatment
por: Anne Gowda, Vidya Mallipattana, et al.
Publicado: (2019)

Microarray-based gene expression profiling for early detection of oral squamous cell carcinoma
por: Ramaswamyreddy, Shwetha Hulimavu, et al.
Publicado: (2018)

Cancer and physical activity
por: Kokila, Ganganna, et al.
Publicado: (2017)

Dichotomy of exosomes in oral squamous cell carcinoma: Prey or play!
por: Shwetha, H R, et al.
Publicado: (2019)

Modifications and recent updates in the 8(th) edition of tumor node metastasis staging pertaining to oropharynx and oral cavity
por: Smitha, T, et al.
Publicado: (2018)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Trends in oral squamous cell carcinoma: Diagnosis for effective, evidence-based treatment 2017
por: Thavarajah, Rooban, et al.
Publicado: (2017)

Extracellular matrix in invasion and metastasis of oral squamous cell carcinoma
por: Kumar, K Vinod, et al.
Publicado: (2019)

Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma
por: Rao, Umadevi Krishna Mohan, et al.
Publicado: (2018)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study
por: Jørgensen, Susanne F., et al.
Publicado: (2021)

Tryptophan metabolism and disposition in cancer biology and immunotherapy
por: Badawy, Abdulla A.-B.
Publicado: (2022)

Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)

T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signatures
por: Elliot, Thomas A.E., et al.
Publicado: (2023)

Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies
por: Kitamura, Takanori
Publicado: (2023)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

A brief outlook on the current emerging trends of COVID 19 vaccines
por: Smitha, T, et al.
Publicado: (2020)

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
por: Pinter, Matthias, et al.
Publicado: (2017)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Expression of CD 20 B-Lymphocyte in oral epithelial dysplasia and oral squamous cell carcinoma: A comparative immunohistochemistry study
por: Thomas, Anela, et al.
Publicado: (2023)

A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway
por: Wu, Chia‐Lun, et al.
Publicado: (2018)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

The paradigm of drug resistance in cancer: an epigenetic perspective
por: Adhikari, Swagata, et al.
Publicado: (2022)

Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
por: Karlsson, Mona, et al.
Publicado: (2010)

Mammalian orthoreovirus can exit cells in extracellular vesicles
por: Smith, Sydni Caet, et al.
Publicado: (2023)

Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
por: Ma, Wanru, et al.
Publicado: (2018)

Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022)
por: Huang, Xiaojuan, et al.
Publicado: (2023)

Intratumor heterogeneity: A new perspective on colorectal cancer research
por: Zheng, Zicheng, et al.
Publicado: (2020)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
por: Barrett, Richard Lee, et al.
Publicado: (2020)

Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer
por: Wang, Qing, et al.
Publicado: (2021)

Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2021)

How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
por: Kathirgamakarthigeyan, Sangary, et al.
Publicado: (2022)

Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
por: Wang, Shixiang, et al.
Publicado: (2019)

Global research trends on immunotherapy in cancer: A bibliometric analysis
por: Yao, Zhichao, et al.
Publicado: (2023)

Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
por: Gutwillig, Amit, et al.
Publicado: (2022)

Advances in immunotherapy for cervical cancer
por: Grau-Bejar, Juan Francisco, et al.
Publicado: (2023)

The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
por: Liu, Jin, et al.
Publicado: (2020)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
por: Duan, Jingjing, et al.
Publicado: (2018)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_clc1kogk0085pt7s7seidsokpc